Merus Bv Stock Today
| MRUS Stock | USD 48.36 0.86 1.81% |
Performance14 of 100
| Odds Of DistressLess than 34
|
Merus BV is selling for under 48.36 as of the 5th of May 2024; that is 1.81 percent increase since the beginning of the trading day. The stock's lowest day price was 47.99. Merus BV has about a 34 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for Merus BV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of April 2024 and ending today, the 5th of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 19th of May 2016 | Category Healthcare | Classification Health Care |
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands. Merus NV is traded on NASDAQ Exchange in the United States.. The company has 58.69 M outstanding shares of which 3.29 M shares are now shorted by private and institutional investors with about 6.58 trading days to cover. More on Merus BV
Moving together with Merus Stock
| 0.76 | LLY | Eli Lilly | PairCorr |
Moving against Merus Stock
| 0.42 | AMGN | Amgen Inc | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Merus Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Merus BV's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Merus BV or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Hui Liu | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Merus BV report their recommendations after researching Merus BV's financial statements, talking to executives and customers, or listening in on Merus BV's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Merus BV. The Merus consensus assessment is calculated by taking the average forecast from all of the analysts covering Merus BV. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Merus BV's liquidity, profitability, solvency, and operating efficiency, Merus BV is not in a good financial situation at this time. It has a very high odds of going through financial crisis in June. Financial strength of Merus BV is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Merus BV's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Merus BV's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Merus BV's financial leverage. It provides some insight into what part of Merus BV's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Merus BV (MRUS) is traded on NASDAQ Exchange in USA. It is located in Uppsalalaan 17, Utrecht, Netherlands, 3584 CT and employs 172 people. Merus BV is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.84 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merus BV's market, we take the total number of its shares issued and multiply it by Merus BV's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Merus BV conducts business under Biotechnology sector and is part of Health Care industry. The entity has 58.69 M outstanding shares of which 3.29 M shares are now shorted by private and institutional investors with about 6.58 trading days to cover.
Merus BV currently holds about 376.11 M in cash with (142.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.2.
Check Merus BV Probability Of Bankruptcy
Ownership AllocationMerus BV holds a total of 58.69 Million outstanding shares. The majority of Merus BV outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Merus BV to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Merus BV. Please pay attention to any change in the institutional holdings of Merus BV as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Merus Ownership Details
Merus Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Merus BV jumping above the current price in 90 days from now is about 11.87%. The Merus BV probability density function shows the probability of Merus BV stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.0084. This indicates Merus BV market returns are related to returns on the market. As the market goes up or down, Merus BV is expected to follow. Additionally, merus BV has an alpha of 0.4129, implying that it can generate a 0.41 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Merus BV to move above the current price in 90 days from now is about 11.87 (This Merus BV probability density function shows the probability of Merus Stock to fall within a particular range of prices over 90 days) .
Merus Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Merus BV that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Merus BV's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Merus BV's value.| Instituion | Recorded On | Shares | |
| Medicxi Ventures Management (jersey) Ltd | 2023-12-31 | 1.6 M | |
| Blackrock Inc | 2023-12-31 | 1.4 M | |
| Driehaus Capital Management Llc | 2023-12-31 | 1.3 M | |
| Balyasny Asset Management Llc | 2023-12-31 | 1.2 M | |
| Pictet Asset Manangement Sa | 2023-12-31 | 1.2 M | |
| Venbio Select Advisor Llc | 2023-12-31 | 888.9 K | |
| Rock Springs Capital Management Lp | 2023-12-31 | 872.1 K | |
| Goldman Sachs Group Inc | 2023-12-31 | 773.9 K | |
| Fmr Inc | 2023-12-31 | 730.5 K | |
| Commodore Capital Lp | 2023-12-31 | 4.7 M | |
| Deerfield Management Co | 2023-09-30 | 3.9 M |
Merus BV Historical Income Statement
Merus BV Income Statement is one of the three primary financial statements used for reporting Merus's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Merus BV revenue and expense. Merus BV Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Merus BV's Tax Provision is comparatively stable compared to the past year. Net Interest Income is likely to gain to about 11.3 M in 2024, whereas Total Revenue is likely to drop slightly above 25.2 M in 2024. View More FundamentalsMerus Stock Against Markets
Picking the right benchmark for Merus BV stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Merus BV stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Merus BV is critical whether you are bullish or bearish towards Merus BV at a given time. Please also check how Merus BV's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Merus BV without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Merus BV Corporate Management
Elected by the shareholders, the Merus BV's board of directors comprises two types of representatives: Merus BV inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merus. The board's role is to monitor Merus BV's management team and ensure that shareholders' interests are well served. Merus BV's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merus BV's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter JD | Company EVP | Profile | |
| Ashley PharmD | Senior Affairs | Profile | |
| Kathleen Farren | IR Officer | Profile | |
| Gregory Perry | Chief Officer | Profile | |
| Hennie Hoogenboom | CoFounder Advisor | Profile | |
| Alexander Bakker | Chief VP | Profile | |
| Cecilia Geuijen | Chief VP | Profile |
How to buy Merus Stock?
Before investing in Merus BV, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Merus BV. To buy Merus BV stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Merus BV. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Merus BV stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Merus BV stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Merus BV stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Merus BV, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Merus Stock please use our How to Invest in Merus BV guide.
Already Invested in Merus BV?
The danger of trading Merus BV is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Merus BV is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Merus BV. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Merus BV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Merus BV is a strong investment it is important to analyze Merus BV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Merus BV's future performance. For an informed investment choice regarding Merus Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merus BV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Merus Stock please use our How to Invest in Merus BV guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Merus Stock analysis
When running Merus BV's price analysis, check to measure Merus BV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merus BV is operating at the current time. Most of Merus BV's value examination focuses on studying past and present price action to predict the probability of Merus BV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merus BV's price. Additionally, you may evaluate how the addition of Merus BV to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Merus BV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merus BV. If investors know Merus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merus BV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.00) | Revenue Per Share 0.852 | Quarterly Revenue Growth (0.16) | Return On Assets (0.24) | Return On Equity (0.51) |
The market value of Merus BV is measured differently than its book value, which is the value of Merus that is recorded on the company's balance sheet. Investors also form their own opinion of Merus BV's value that differs from its market value or its book value, called intrinsic value, which is Merus BV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merus BV's market value can be influenced by many factors that don't directly affect Merus BV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merus BV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merus BV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merus BV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.